Alternate Dosing Regimens of BG00012 in Healthy Volunteers
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and PK of different doses
and dosing regimens of BG00012 administered with and without ASA compared to placebo.